Earnings Call · Q2 FY2021·2021-08-10

Q2 21EPS +10.00%·Rev n/aQ1 21EPS -22.22%·Rev n/aQ4 20EPS +22.22%·Rev n/aQ3 20EPS +20.00%·Rev n/a⚠ consensus missing

CATALYST PHARMACEUTICALS, INC. CPRX

Ali Grande — Investor Relations or Corporate Communications

Patrick McEnany — Chairman and Chief Executive Officer

Jeffrey Del Carmen — Chief Commercial Officer

Steven Miller — Chief Operating Officer

−0.9%1d on move date−0.8% vs SPY3d+2.4%5d+4.0%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CPRX calls or request research access.

More CPRX calls Browse calls Request research access